A Double-Blind, 3-Part Crossover Study to Assess the Pharmacokinetics and Tolerability of Single Doses of Gabapentin Enacarbil and Morphine Administered Alone and in Combination in Healthy Subjects

Trial Profile

A Double-Blind, 3-Part Crossover Study to Assess the Pharmacokinetics and Tolerability of Single Doses of Gabapentin Enacarbil and Morphine Administered Alone and in Combination in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Nov 2014

At a glance

  • Drugs Gabapentin enacarbil (Primary) ; Morphine
  • Indications Pain; Restless legs syndrome
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline; XenoPort
  • Most Recent Events

    • 15 Jul 2013 Lead trial centre amended as reported by ClinicalTrials.gov.
    • 24 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top